Researcher Profile

Researcher Profile

John Flanagan, PhD

John Flanagan, PhD

Professor, Department of Biochemistry and Molecular Biology
Scientific Program:Next-Generation Therapies

Research Interests

  • Proteins
  • Escherichia coli
  • Peptides
  • Adenosine Triphosphatases
  • X-Rays
  • DNA
  • Adenosine Triphosphate
  • Amino Acids
  • Mutation
  • Nucleic Acids
  • Transfer RNA
  • Occludin

Recent Publications


Bewley, MC, Reinhart, L, Stake, MS, Nadaraia-Hoke, S, Parent, LJ & Flanagan, JM 2017, 'A non-cleavable hexahistidine affinity tag at the carboxyl-terminus of the HIV-1 Pr55Gag polyprotein alters nucleic acid binding properties', Protein Expression and Purification, vol. 130, pp. 137-145.
Clark, DN, Flanagan, JM & Hu, J 2017, 'Mapping of functional subdomains in the terminal protein domain of hepatitis B virus polymerase', Journal of virology, vol. 91, no. 3, e01785-16.


Rye-McCurdy, T, Olson, ED, Liu, S, Binkley, C, Reyes, JP, Thompson, BR, Flanagan, JM, Parent, LJ & Musier-Forsyth, K 2016, 'Functional equivalence of retroviral MA domains in facilitating Psi RNA binding specificity by Gag', Viruses, vol. 8, no. 9, 256.
Bolinger, MT, Ramshekar, A, Waldschmidt, HV, Larsen, SD, Bewley, MC, Flanagan, JM & Antonetti, DA 2016, 'Occludin S471 phosphorylation contributes to epithelial monolayer maturation', Molecular and cellular biology, vol. 36, no. 15, pp. 2051-2066.

Clinical Trials Search

Children (age < 18 years)
Adults (age >= 18 years)